“Uncovering Potential Investor Claims: Pomerantz Law Firm Investigates Neurogene Inc. – NGNE”
The Investigation of Neurogene Inc. by Pomerantz LLP New York, Jan. 21, 2025 – Pomerantz LLP is currently conducting an investigation into claims on behalf of investors of Neurogene Inc. (NASDAQ: NGNE). Background Neurogene Inc. is a pharmaceutical company that focuses on developing treatments for genetic neurological disorders. Recently, there have been claims made against…